Skip to main content

Month: September 2024

Power REIT Receives Notice Resolving NYSE American Listing Standards Deficiency

Old Bethpage, New York, Sept. 26, 2024 (GLOBE NEWSWIRE) — Power REIT (NYSE-AMEX: PW and PW.PRA) (“Power REIT” or the “Trust”), today announced that it received a notice from the NYSE American LLC rescinding its letter dated September 3, 2024 (the “Deficiency Letter”). As previously disclosed, the Deficiency Letter stated that the Trust was not in compliance with the continued listing standards of the Exchange because the Trust was below compliance with Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”), requiring stockholders’ equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. As part of evaluating a plan to comply with the NYSE American listing requirements, the Trust embarked on analysis of the accounting...

Continue reading

Urteste Expands Development of Innovative Diagnostic Projects

               Urteste Expands Development of Innovative Diagnostic Projects Gdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET – Urteste S.A. (Warsaw Stock Exchange: URT),  a biotechnology company specializing in the development of breakthrough technology to detect cancer from urine samples, best known for its flagship project PANURI, a diagnostic test for pancreatic cancer. The company’s breakthrough technology allows for early detection of cancer by measuring the activity of enzymes present in urine using proprietary synthetic peptides. One urine sample can be used to screen for many types of cancers. Urteste technology is non-invasive, low-cost to produce, and has high sensitivity and specificity, with results available in up to 2 hours. The diagnostic process is automated to minimize the likelihood of human error.A proof-of-concept...

Continue reading

Stolt-Nielsen Limited to Present the Results for the Third Quarter of 2024

Stolt-Nielsen Limited to Present the Results for the Third Quarter of 2024 LONDON, September 26, 2024 – Stolt-Nielsen Limited (Oslo Børs: SNI) will host a presentation to discuss the Company’s unaudited results for the third quarter of 2024 on Wednesday, October 2, 2024 at 15:00 CEST (09:00 EDT, 14:00 BST). The presentation will be hosted by: –        Mr. Udo Lange – Chief Executive Officer, Stolt-Nielsen Limited –        Mr. Jens F. Grüner-Hegge – Chief Financial Officer, Stolt-Nielsen Limited –        Mr. Alex Ng – Vice President Strategy & Business Development, Stolt-Nielsen Limited For investors, analysts and journalists who wish to attend in person, the presentation is being held at SEB, Filipstad Brygge 1, 0252 Oslo, Norway. Those who wish to participate in the live presentation online...

Continue reading

Stryve Foods Enters Pet Category with Launch of HIGH STEAKS Pet Treats

PLANO, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), a pioneer in creating healthy and convenient protein snacks, announces the launch of High Steaks, an innovative brand dedicated to providing high-quality, high-protein, human-grade pet treats. Stryve Foods, known for air-dried meat snacks under the brands Stryve, Vacadillos, and Kalahari, is bringing their premium, high protein, 0g sugar, simple ingredient meat products to your pet. High Steaks human-grade pet treats, are the perfect on-the-go solution for an active, and healthy dog.High Steaks treats feature real, air-dried beef as the primary component. Each treat is formulated to deliver the essential proteins that pets need for energy, muscle development, and optimal health. The brand aims to meet the growing demand...

Continue reading

New Research Findings Reveal Employers Who Contribute to HSAs See Double-Digit Growth in Employee Participation

New HealthEquity research indicates employers who optimize HSA contribution strategies are more directly supporting their employees’ financial well-being DRAPER, Utah, Sept. 26, 2024 (GLOBE NEWSWIRE) — HealthEquity, Inc. (Nasdaq: HQY) (“HealthEquity”) today released research findings on how Health Savings Account (HSA) contribution strategies influence how employees participate in their HSA benefits. The qualitative and quantitative analysis included a sample of nearly 2,000 HealthEquity clients and more than 2 million HSA members. The analysis provides insight for employers who want to create impactful HSA benefit strategies that support their employees’ financial wellbeing. “Benefit leaders want employees to get the most out of their benefits — including HSAs — and fostering utilization is a constant challenge,” said...

Continue reading

Armlogi Reports 24% Revenue Growth for Fiscal Year 2024

Conference Call and Webcast on September 26th at 1:30 PM Pacific Time WALNUT, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today provided a business update, and reported financial results for the fiscal year ended June 30, 2024. Fiscal Year 2024 Financial Results:Total revenue increased by $31.9 million, or 23.6%, to $167.0 million during the fiscal year ended June 30, 2024, compared to $135.0 million for the fiscal year ended June 30, 2023.Our transportation services segment reported revenue of $115.3 million, an increase of 18.8% from $97.0 million in fiscal year 2023. The increase was driven...

Continue reading

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing

DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This report provides an in-depth analysis of drug trends within educational institutions, shedding light on the growing challenges schools face in maintaining a drug-free environment for students and staff. Following the success of our inaugural Workforce Insights Report earlier this year, we continue our commitment to providing groundbreaking insights based on data from hair testing. For the Education Insights Report, Psychemedics analyzed thousands of hair samples collected from students and staff in educational settings across the United States. The data offer valuable perspectives on drug use trends over the past...

Continue reading

Finning Announces Executive Leadership Transition

VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) today announced an executive leadership team transition update as part of our succession planning process and to accelerate the execution of our strategic plan. Finning places significant value on succession planning and smooth leadership transitions. As we expand our planning horizons, it is important to ensure the renewal of our executive team and that we have our best talent deployed to the biggest opportunities. Tim Ferwerda, current managing director of Finning UK and Ireland, will transition to the role of president of Finning Canada. David Primrose, current president of Finning Canada, will support Tim’s transition and assume the role of executive vice president and chief development...

Continue reading

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to January 31, 2025. Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of. Scilex’s transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to January 31, 2025.PALO ALTO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the U.S. Bankruptcy Court for the Southern District of Texas...

Continue reading

Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors

Appointment indicates Hapbee’s commitment to expand in the Middle East and globally MONTRÉAL, Sept. 26, 2024 (GLOBE NEWSWIRE) — CNW Telbec/ – Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), a leading provider of wellness wearable technology, is pleased to announce that Mr. Abdulla Al Zain has been appointed as an additional director on the Board effective September 16th, 2024. Mr. Al Zain succeeds Robert Dzisiak, who has served as a member of the Board since Hapbee’s inception. The company thanks Mr. Dzisiak for his service. Mr. Abdulla Al Zain brings a wealth of experience across a number of critical asset classes for Hapbee, such as hospitality, sports and financial services, particularly across Europe and the Middle East. He is the Chairman and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.